Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CYTK
CYTK logo

CYTK News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CYTK News

Cytokinetics Executive's Major Stock Sale Raises Eyebrows

1d agoFool

Cytokinetics Executive Sells Stock Options

1d agoNASDAQ.COM

MongoDB and Warner Bros Options Trading Activity

Feb 25 2026NASDAQ.COM

Cytokinetics Q4 2025 Earnings Call Highlights

Feb 25 2026seekingalpha

Cytokinetics (CYTK) Q4 2025 Earnings Transcript

Feb 25 2026NASDAQ.COM

Cytokinetics Q4 Earnings Report Analysis

Feb 24 2026seekingalpha

Cytokinetics' MYQORZO Approved and U.S. Launch Underway

Feb 24 2026Yahoo Finance

Cytokinetics to Announce Q4 Earnings on February 24

Feb 23 2026seekingalpha

CYTK Events

No data

No data

CYTK Monitor News

Cytokinetics Faces Challenges Despite FDA Approval of MYQORZO

Feb 25 2026

Cytokinetics to Announce Q4 Earnings Amid FDA Approval for Aficamten

Feb 24 2026

Cytokinetics stock rises amid sector rotation despite shareholder investigation

Jan 06 2026

Cytokinetics Receives FDA Approval for MYQORZO, Driving Stock Surge

Dec 22 2025

Cytokinetics faces shareholder investigation amid FDA review delay

Dec 17 2025

CYTK Earnings Analysis

Cytokinetics Earnings Report: Key Highlights & Forecast- Intellectia AI™
4 months ago
Cytokinetics Q4 2024: Earnings Growth & Strategic Milestones- Intellectia AI™
1 years ago

People Also Watch